Trial No.: AbbVie 14-064
Phase 2 Study Comparing Efficacy and Safety of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine/Oxaliplatin-Based Regimen and Bevacizumab Site Initiation Vist: March 16. Opening late March.
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.